| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |